Focus oncology development on the patient, manage trial complexity, and increase predictability and speed.
IQVIA's 12 therapeutic and 6 cross-therapeutic Centers of Excellence have been involved in the development of nearly three out of every four FDA-approved drugs since 2016. Read this fact sheet to discover more about how we are committed to advancing scientific innovation and can help accelerate your trial speed, allowing you to bring treatments to patients faster.
Focus oncology development on the patient, manage trial complexity, and increase predictability and speed.
Accelerate your obesity trial timelines with solutions designed for rapid execution by leveraging our team of seasoned experts and advanced patient recruitment solutions.
Access broad and deep neurology expertise to reduce costs, accelerate timelines and manage risk, from clinical trials to evidence generation and beyond.
Build on our experience of more than 245 rare disease studies in 96 countries to fulfill your promise of hope to millions around the world.
Access new resources for advanced therapy development, from candidate identification through market authorization.